Intrinsic Value of S&P & Nasdaq Contact Us

Nuvalent, Inc. NUVL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$137.44
+30.9%

Nuvalent, Inc. (NUVL) has a consensus analyst rating of Buy, based on 14 analysts covering the stock. Of those, 14 recommend buying, 0 recommend holding, and 0 recommend selling.

The analyst consensus price target for NUVL is $137.44, representing a +30.9% upside from the current price of $105.02. Price targets range from a low of $120.00 to a high of $155.00.

Analyst Consensus — NUVL

Buy
Strong Buy
0
Buy
14
Hold
0
Sell
0
Strong Sell
0
14 analysts
Price Targets
Consensus$137.44
High$155.00
Low$120.00
Median$135.00
Last Month Avg-
Last Quarter Avg-
Last Year Avg$132.83
All-Time Count20
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message